Factors related to silent myocardial damage in hemodialysis patients

Renal Failure

Volumn 31, Issue 10, 2009, Pages 933-941

  Afsar, Baris ^a   Elsurer, Rengin ^a   Akgul, Arzu ^a   Sezer, Siren ^a   Ozdemir, Fatma Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Hemodialysis; Myocardial damage; Nontraditional; Traditional; Troponin I; Tumor necrosis factor alpha

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SILENT MYOCARDIAL INFARCTION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; RENAL DIALYSIS; RISK FACTORS; TROPONIN I;

EID: 73649137867     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903216139     Document Type: Article

References (40)

1. Santoro A, Mancini E. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002;17:10-15.
2. Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38:405-416.
3. Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, Dahlmeier BA, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A one-year outcomes analysis. Am J Kidney Dis. 1997;29:399-403.
4. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis. J Am Coll Cardiol. 2001;38:991-998.
5. Wayand D, Baum H, Schätzle G, Schärf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000;46:1345-1350.
6. Schulz O, Sigusch HH. Impact of an exercise-induced increase in cardiac troponin I in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2002;90:547-550.
7. Roberts MA, Fernando D, Macmillan N, Proimos G, Bach LA, Power DA, et al. Single and serial measurements of cardiac troponin I in asymptomatic patients on chronic hemodialysis. Clin Nephrol. 2004;61:40-46.
8. Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, et al. Cardiac troponin I (2nd generation assay) in chronic hemodialysis patients: Prevalence and prognostic value. Nephrol Dial Transplant. 2003;18:942-946.
9. Stoffel MP, Pollok M, Baldamus CA. Troponin I is a better prognostic parameter of cardiovascular events in asymptomatic patients on hemodialysis than troponin T. Nephrol Dial Transplant. 2000;15:1259-1260.
10. Troyanov S, Ly QH, Schampaert E, Ammann H, Lalumière G, Madore F, et al. Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: A three year prospective study. Heart. 2005;91:1227-1228.
11. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, et al. Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients. Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant. 2001;16:1452-1458.
12. Konno T, Shimizu M, Ino H, Fujino N, Hayashi K, Uchiyama K, et al. Differences in diagnostic value of four electrocardiographic voltage criteria for hypertrophic cardiomyopathy in a genotyped population. Am J Cardiol. 2005;96:1308-1312.
13. Knebel F, Schimke I, Eddicks S, Walde T, Ziebig R, Schattke S, et al. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury? Cardiovasc Ultrasound. 2005;17:3-21.
14. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 2002;39:1917-1923.
15. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47.
16. Wang M, Tsai BM, Crisostomo PR, Meldrum DR. Tumor necrosis factor receptor signaling resistance in the female myocardium during ischemia. Circulation. 2006;114: I282-1289.
17. Kubota T, Miyagishima M, Frye CS, Alber SM, Bounoutas GS, Kadokami T, et al. Overexpression of tumor necrosis factor-alpha activates both anti- and pro-apoptotic pathways in the myocardium. J Mol Cell Cardiol. 2001;33:1331-1344.
18. Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafè M, Marchegiani F, et al. Tumor necrosis factor-alpha gene- 308G. A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis. 2005;16:489-493.
19. Löwbeer C, Stenvinkel P, Pecoits-Filho R, Heimbürger O, Lindholm B, Gustafsson SA, et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J. Intern Med. 2003;253:153-160.
20. Löwbeer C, Ottosson-Seeberger A, Gustafsson SA, Norrman R, Hulting J, Gutierrez A. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant. 1999;14:1948-1955.
21. Tun A, Khan IA, Win MT, Hussain A, Hla TA, Wattanasuwan N, et al. Specificity of cardiac troponin I and creatine kinase- MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology. 1998;90:280-285.
22. Solaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res. 1999;84:122-124.
23. Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant. 1998;13:1709-1712.
24. Missov E, Calzolari C, Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation. 1997;96:2953-2958.
25. Mashimo Y, Suzuki Y, Hatori K, Tabara Y, Miki T, Tokunaga K, et al. Association of TNFRSF4 gene polymorphisms with essential hypertension. J Hypertens. 2008;26:902-913.
26. Bacaner M, Brietenbucher J, LaBree J. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: Is ischemic heart disease primarily adrenergic cardiovascular disease? Am J Ther. 2004;11:366-411.
27. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, et al. Plasma interleukin-6 and tumor necrosis factoralpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res. 2007;30:541-548.
28. Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG. Oxidative stress in malignant and nonmalignant phase hypertension. J Hum Hypertens. 2002;16:333-336.
29. Ritz E. Atherosclerosis in dialyzed patients. Blood Purif. 2004;22:28-37.
30. Li S, Collins AJ. Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int. 2004;65:626-633.
31. Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation. 1969;39:503-515.
32. Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1999;33:63-72.
33. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251-1263.
34. Levin A. The role of anaemia in the genesis of cardiac abnormalities in patients with chronic kidney disease. Nephrol Dial Transplant. 2002;17:207-210.
35. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003;13: 15-25.
36. Shinaberger CS, Kilpatrick RD, Regidor DL, McAllister CJ, Greenland S, Kopple JD, et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis. 2006;48:37-49.
37. Kumagai H, Sakurai M, Takita T, Maruyama Y, Uno S, Ikegaya N, et al. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients. Am J Kidney Dis. 2006;48:797-805.
38. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next? Semin Dial. 2005;18:365-369.
39. Caglar M, Mahmoudian B, Aytemir K, Kahraman S, AriciM, Kabakci G, et al. Value of 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for the detection of silent myocardial ischemia in hemodialysis patients: Clinical variables associated with abnormal test results. Nucl Med Commun. 2006;27:61-69.
40. Katerinis I, Nguyen Q, Magnin JL, Descombes E. Cardiacfindings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels. Ren Fail. 2008;30:357-362.